Serotonergic antidepressant drugs and L‐dopa‐induced dyskinesias in Parkinson's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0404|131|3|191-195

ISSN： 0001-6314

Source： ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol.131, Iss.3, 2015-03, pp. : 191-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonergic markers in Parkinson's disease and levodopa‐induced dyskinesias

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 6, 2015-05 ,pp. : 796-804

John Wiley & Sons Inc

Access to resources Recommend Favorite

L‐Dopa Treatment of Parkinson's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 30, Iss. 5, 1982-05 ,pp. : 322-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nicotine reduces established levodopa‐induced dyskinesias in a monkey model of Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1398-1406

John Wiley & Sons Inc

Access to resources Recommend Favorite

The motor inhibition system in Parkinson's disease with levodopa‐induced dyskinesias

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 14, 2015-12 ,pp. : 1912-1920

John Wiley & Sons Inc

Access to resources Recommend Favorite

Zooming in on the small: The plasticity of striatal dendritic spines in l‐DOPA–Induced dyskinesia

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 484-493

John Wiley & Sons Inc

Access to resources Recommend Favorite